Research Scientist at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

PhD degree in related life sciences OR Master's degree in related life sciences and 4+ years of experience in cell biology, molecular biology, or biochemistry in biotechnology or pharmaceutical industry OR Bachelor's degree in related life sciences and 6+ years of experience in cell biology, molecular biology, or biochemistry in biotechnology or pharmaceutical industry
Preferred: PhD degree in Cell Biology, Molecular Biology, or Immunology with 3+ years postdoctoral training in cancer cell biology supported by impactful publications
Preferred: Deep and broad knowledge of cancer biology, oncology targets and signaling pathways
Demonstrated scientific rigor, independence and scientific achievements
Strong organizational and planning skills
Ability to think critically and creatively
Ability to work independently as well as part of collaborative teams

Responsibilities

Lead the initiation and/or advancement of oncology projects into the pipeline using in vitro and in vivo methodologies
Participate in nomination of new targets
Direct, independently plan, execute, analyze, and interpret complex experiments to identify or validate novel targets, elucidate target biology, elucidate drug candidates’ mechanism of action
Develop assays to measure pharmacodynamic markers, kinetics of drug response
Train and mentor junior scientists or direct members of project teams in the initiation and execution of experimental plans
Manage multiple projects simultaneously and work cross-functionally with colleagues in the oncology, in vivo pharmacology, bioinformatics, medicinal chemistry, DMPK and other relevant functions
Proactively evaluate new technologies and implement new approaches to enhance our understanding of disease mechanisms
Present research findings and recommendations to leadership, author and contribute to research reports, manuscripts, IND and patent filings
Cultivate a culture that embraces scientific excellence, urgency, partnerships with key stakeholders, continuous learning and improvement, taking proactive role in personal growth and development

Skills

Oncology Research

Drug Discovery

Therapeutic Development

Cancer Research

Project Leadership

Biotechnology

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free